ClearFlow has been awarded a group purchasing agreement—chest drainage contract: Contract # PP-OR-1561—for the chest drainage products category with Premier. A press release reports that the PleuraFlow ACT System is indicated for use following cardiothoracic surgical procedures and chest trauma. Its Active Clearance Technology is designed to proactively inhibit and disrupt clot formation inside the chest tube to reduce the likelihood of chest tube occlusion.
The press release adds that improving drainage by maintaining chest tube patency has been shown to improve patient outcomes reducing the incidence of common complications such as pleural, pericardial effusions and new-onset post-operative atrial fibrillation.
Premier is a healthcare improvement company, uniting an alliance of approximately 3,900 US hospitals and 150,000 other providers to transform healthcare. With integrated data and analytics, collaborative supply chain solutions and advisory and other services, Premier aims to enable better care and outcomes at a lower cost.
Paul Molloy, CEO of ClearFlow, states: “ClearFlow is proud to now be able to bring its Active Clearance Technology devices to Premier members under these new arrangements with one of the country’s leading GPOs. ClearFlow’s founding principles are directed toward improving patient outcomes and lowering the total cost of healthcare for all participants in the medical eco-system and these principles closely align with the membership objectives of the Premier organisation.”